Literature DB >> 17169578

Remifentanil administration reveals biphasic phMRI temporal responses in rat consistent with dynamic receptor regulation.

Christina H Liu1, Doug N Greve, Guangping Dai, John J A Marota, Joseph B Mandeville.   

Abstract

Many pharmacological stimuli influence multiple neurotransmitter systems in the brain, and the dynamics of the functional brain response can vary regionally. In this study, the temporal response of cerebral blood volume (CBV) was employed to spatially segment cerebral effects due to infusion of a potent mu-opioid receptor agonist. Repeated intravenous injection of 10 mug/kg remifentanil in rats caused reproducible regional positive, negative, and biphasic changes in CBV. Three temporal processes were identified in the cerebral response and analyzed within the framework of the general linear model. Firstly, a slow component identified CBV changes that were almost exclusively negative, and the spatial distribution was similar to the inhibition produced by morphine (200 microg/kg). The largest CBV reductions occurred in caudate, accumbens, ventral hippocampus, cingulate, and piriform cortex. Secondly, a more rapid temporal component corresponded primarily with a regional distribution of positive changes in CBV consistent with GABAergic inhibition of hippocampal interneurons and associated projections. Thirdly, a response with the dynamics of mean arterial blood pressure correlated positively with CBV changes in hypothalamus, consistent with a central mechanism for control of blood pressure. We propose that the dominant source of the temporal variance in signal is dynamic modulation of drug targets by receptor endocytosis, an established effect in vitro. These results suggest that the temporal response of fMRI signal reflects underlying neurobiological processes, so that temporal decomposition strategies may aid interpretation of pharmacological mechanisms by identifying interconnected regions or those associated with common neural targets and processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169578      PMCID: PMC1850955          DOI: 10.1016/j.neuroimage.2006.10.028

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  56 in total

1.  Voxel similarity measures for 3-D serial MR brain image registration.

Authors:  M Holden; D L Hill; E R Denton; J M Jarosz; T C Cox; T Rohlfing; J Goodey; D J Hawkes
Journal:  IEEE Trans Med Imaging       Date:  2000-02       Impact factor: 10.048

2.  Determination of drug-induced changes in functional MRI signal using a pharmacokinetic model.

Authors:  A S Bloom; R G Hoffmann; S A Fuller; J Pankiewicz; H H Harsch; E A Stein
Journal:  Hum Brain Mapp       Date:  1999       Impact factor: 5.038

3.  Pharmacological magnetic resonance imaging: a new application for functional MRI.

Authors:  R A Leslie; M F James
Journal:  Trends Pharmacol Sci       Date:  2000-08       Impact factor: 14.819

4.  Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in Rat.

Authors:  J J Marota; J B Mandeville; R M Weisskoff; M A Moskowitz; B R Rosen; B E Kosofsky
Journal:  Neuroimage       Date:  2000-01       Impact factor: 6.556

5.  Receptor density and recycling affect the rate of agonist-induced desensitization of mu-opioid receptor.

Authors:  P Y Law; L J Erickson; R El-Kouhen; L Dicker; J Solberg; W Wang; E Miller; A L Burd; H H Loh
Journal:  Mol Pharmacol       Date:  2000-08       Impact factor: 4.436

6.  Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats.

Authors:  Y B Shah; L Haynes; M J W Prior; C A Marsden; P G Morris; V Chapman
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

7.  Seizure-like events in disinhibited ventral slices of adult rat hippocampus.

Authors:  C Borck; J G Jefferys
Journal:  J Neurophysiol       Date:  1999-11       Impact factor: 2.714

8.  Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting.

Authors:  M D Ehlers
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

9.  Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system.

Authors:  Alvaro Díaz; Jesús Flórez; Angel Pazos; María A Hurlé
Journal:  Pain       Date:  2000-06       Impact factor: 6.961

10.  Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats.

Authors:  L V Panlilio; C W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2000-05       Impact factor: 4.530

View more
  19 in total

1.  Longitudinal monitoring of motor neuron circuitry in FALS rats using in-vivo phMRI.

Authors:  Ji-Kyung Choi; Alpaslan Dedeoglu; Bruce G Jenkins
Journal:  Neuroreport       Date:  2010-02-17       Impact factor: 1.837

2.  Rodent Cerebral Blood Volume (CBV) changes during hypercapnia observed using Magnetic Particle Imaging (MPI) detection.

Authors:  Clarissa Zimmerman Cooley; Joseph B Mandeville; Erica E Mason; Emiri T Mandeville; Lawrence L Wald
Journal:  Neuroimage       Date:  2018-05-05       Impact factor: 6.556

3.  Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists.

Authors:  Ji-Kyung Choi; Joseph B Mandeville; Y Iris Chen; Peter Grundt; Susanta K Sarkar; Amy H Newman; Bruce G Jenkins
Journal:  Psychopharmacology (Berl)       Date:  2010-07-14       Impact factor: 4.530

4.  Dynamic functional cerebral blood volume responses to normobaric hyperoxia in acute ischemic stroke.

Authors:  Ona Wu; Jie Lu; Joseph B Mandeville; Yoshihiro Murata; Yasu Egi; Guangping Dai; John J Marota; Izzuddin Diwan; Rick M Dijkhuizen; Kenneth K Kwong; Eng H Lo; Aneesh B Singhal
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-27       Impact factor: 6.200

5.  Endogenous opioid-dopamine neurotransmission underlie negative CBV fMRI signals.

Authors:  Yen-Yu I Shih; Yun-Chen Chiang; Bai-Chuang Shyu; Fu-Shan Jaw; Timothy Q Duong; Chen Chang
Journal:  Exp Neurol       Date:  2012-01-05       Impact factor: 5.330

Review 6.  Advances in simultaneous PET/MR for imaging neuroreceptor function.

Authors:  Christin Y Sander; Hanne D Hansen; Hsiao-Ying Wey
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-13       Impact factor: 6.200

Review 7.  Data collection and analysis strategies for phMRI.

Authors:  Joseph B Mandeville; Christina H Liu; Wim Vanduffel; John J A Marota; Bruce G Jenkins
Journal:  Neuropharmacology       Date:  2014-03-05       Impact factor: 5.250

8.  CNS animal fMRI in pain and analgesia.

Authors:  David Borsook; Lino Becerra
Journal:  Neurosci Biobehav Rev       Date:  2010-11-30       Impact factor: 8.989

9.  Oxycodone-Mediated Activation of the Mu Opioid Receptor Reduces Whole Brain Functional Connectivity in Mice.

Authors:  Md Taufiq Nasseef; Jai Puneet Singh; Aliza T Ehrlich; Michael McNicholas; Da Woon Park; Weiya Ma; Praveen Kulkarni; Brigitte L Kieffer; Emmanuel Darcq
Journal:  ACS Pharmacol Transl Sci       Date:  2019-06-28

10.  Registering and analyzing rat fMRI data in the stereotaxic framework by exploiting intrinsic anatomical features.

Authors:  Hanbing Lu; Clara A Scholl; Yantao Zuo; Steven Demny; William Rea; Elliot A Stein; Yihong Yang
Journal:  Magn Reson Imaging       Date:  2009-07-15       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.